Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 8,510 | 6,278 | 7,492 | 17,651 | 32,881 |
| Operating Income | -8,510 | -6,278 | -7,492 | -17,651 | -32,881 |
| Other Income | -1,799 | -1,239 | 580 | -215 | 414 |
| Pre-tax Income | -10,309 | -7,517 | -6,912 | -17,866 | -32,467 |
| Net Income Continuous | -10,309 | -7,517 | -6,912 | -17,866 | -32,467 |
| Net Income | $-10,309 | $-7,517 | $-6,912 | $-17,866 | $-32,467 |
| EPS Basic Total Ops | -2.39 | -8.08 | -30.00 | -127.85 | -237.58 |
| EPS Basic Continuous Ops | -2.39 | -8.07 | -29.95 | -127.97 | -237.56 |
| EPS Diluted Total Ops | -2.39 | -8.08 | -30.00 | -127.85 | -237.58 |
| EPS Diluted Continuous Ops | -2.39 | -8.07 | -29.95 | -127.97 | -237.56 |
| EPS Diluted Before Non-Recurring Items | N/A | -8.08 | -30.01 | -127.79 | -237.58 |
| EBITDA(a) | $-8,495 | $-6,212 | $-7,442 | $-17,618 | $-32,718 |